You just read:

Terumo BCT Announces Enrollment of the First Patient in Its U.S. Clinical Trial Designed to Study Platelets Treated With the Mirasol® Pathogen Reduction Technology (PRT) System

News provided by

Terumo BCT

17 May, 2017, 09:58 ET